pharma · Alopecia areata · Multiple myeloma
First Biotech (Australia)
Pfizer Australia Pty Ltd
Pfizer Australia Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Alopecia areata, Multiple myeloma, Heart failure, Acute Migraine (with or without aura), Transthyretin amyloidosi
Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU HQ
2017 Founded
2 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU
- Founded
- 2017
- Employees
- 2
- Programs
- 126
- Drugs
- 208
- Patents
- 0
C3391003
Phase 3 · small molecule · DUCHENNE MUSCULAR DYSTROPHY (DMD)
C3391003 for DUCHENNE MUSCULAR DYSTROPHY (DMD) is a Phase 3 program (small_molecule) at Pfizer Australia Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code C3391003
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Pfizer Australia Pty Ltd
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- DUCHENNE MUSCULAR DYSTROPHY (DMD)
- Status
- active
- Trials
- 1